Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis.

Walsh, Jessica A; Saffore, Christopher D; Collins, Eric B; Ostor, Andrew

Walsh, Jessica A; Saffore, Christopher D; Collins, Eric B; Ostor, Andrew.

Afiliación

Walsh JA; Division of Rheumatology, Clinic 2, Salt Lake City Veterans Affairs and University of Utah, 50 North Medical Drive, Salt Lake City, UT, 84132, USA. Jessica.Walsh@hsc.utah.edu.
Saffore CD; AbbVie Inc., North Chicago, IL, USA.
Collins EB; Medicus Economics LLC, Boston, MA, USA.
Ostor A; Cabrini Medical Center, Monash University, Melbourne, Australia.

Rheumatol Ther ; 10(5): 1385-1398, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37568031

Palabras clave

Ankylosing spondylitis; Network meta-analysis; Treatment effectiveness; Upadacitinib

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Rheumatol Ther Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google